ReviewBMC pulmonary medicine2025
IgG4-related lung disease mimicking COPD: case report and review.
Review in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Tocilizumab in the treatment of IgG4-related disease involving the carotid artery-case report and literature review.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
IgG4-RD is a systemic fibroinflammatory condition with a wide range of clinical presentations, including involvement of the respiratory system. While respiratory manifestations are common, IgG4-RD can mimic more prevalent pulmonary conditions, such as asthma or chronic obstructive pulmonary disease (COPD), making diagnosis particularly challenging. In this case report, we describe a patient whose initial symptoms were consistent with COPD, but further investigation revealed that IgG4-RD was the underlying cause. This case highlights the importance of considering IgG4-RD in the differential diagnosis of atypical or treatment-resistant COPD-like presentations to avoid misdiagnosis and ensure timely, appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.